YEM Search

Plant Summary

Plant Information

TCMBank_ID:	TCMBANKHE005505
ID:	TCMBANKHE005505
植物拉丁名:	polyporus umbellatus
功能与主治:	To transform dampness and promote water metabolism/Inhibited urination, edema, ascites, carcinoma of lung, carcinoma of esophagus, diarrhea, strangury-turbidity, vaginal discharge.
药用植物名:	猪苓
药用部位:	sclerotium
药味:	Mild; Sweet; Neutral
经络:	Bladder; Kidney
治疗类型:	利水渗湿药
TCM_ID_id:	4883
SymMap_id:	488
TCMSP_id:	883

植物对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN001323	ergosta-6-a-3.beta,5.alpha,6β-triol
TCMBANKIN009926	ergosta-7,22-dien-3-one	(22E,24R)-ergosta-7,22-dien-3 β-one; Ergosta-7,22-dien-3-one	C28H44O	396.6 g/mol	CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(=O)C4)C)C
TCMBANKIN011625	ergosta-7,22-diene-3β-ol	(22e,24r)-ergosta-7,22-dien-3beta-ol	C28H46O	398.7 g/mol	CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4)O)C)C
TCMBANKIN023395	polyporoid,b			492.72
TCMBANKIN024395	ergosta-6,22-dien-3β,5α,6β-triol
TCMBANKIN026829	polyporusterone,g			460.72
TCMBANKIN028532	(2S)-2-hydroxylignoceric acid	(2S)-2-hydroxytetracosanoic acid	C24H48O3	384.64
TCMBANKIN028715	polyporoid,a			492.72
TCMBANKIN030322	biotin		C10H16N2O3S	244.31 g/mol	C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2
TCMBANKIN030737	22,23-epoxy-3beta,14alpha,,20beta,24beta-tetrahydroxy-7-en-6-one			476.72
TCMBANKIN030827	polyporoid,c			494.74
TCMBANKIN032162	ergotamine		C33H35N5O5	581.7 g/mol	CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C
TCMBANKIN032185	polyorusterone,f			478.74
TCMBANKIN032887	polyporusterone,a		C28H46O6	478.66
TCMBANKIN033648	ergosta-5,7,22-trien-3-ol		C28H44O	396.6 g/mol	CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CC=C4C3(CCC(C4)O)C)C
TCMBANKIN033857	(2S,3R,5R,9R,10R,13R,14S,17S)-17-[(1R,2R,4S)-1,2-dihydroxy-1,4,5-trimethylhexyl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one	(2S,3R,5R,9R,10R,13R,14S,17S)-17-[(2R,3R,5S)-2,3-dihydroxy-5,6-dimethyl-heptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; (2S,3R,5R,9R,10R,13R,14S,17S)-17-[(1R,2R,4S)-1,2-dihydroxy-1,4,5-trimethyl-hexyl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; (2S,3R,5R,9R,10R,13R,14S,17S)-17-[(2R,3R,5S)-2,3-dihydroxy-5,6-dimethylheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one	C28H46O6	478.66
TCMBANKIN034991	TCMID		C19H11O6-		CC1=CC(=CC2=CC3=C(C(=C12)[O-])C(=O)C4=C(C=C(C=C4C3=O)O)O)O
TCMBANKIN035908	2,5-Dibutylfuran	Furan, 2,5-dibutyl-	C12H20O	180.29	CCCCC1=CC=C(O1)CCCC
TCMBANKIN036363	alpha-hydroxytetrasocsanoic acid
TCMBANKIN037814	(20S,22R,24R)-16,22-epoxy-3beta,14alpha,23beta,25-tetrahydroxyergost-7-en-6-one		C28H44O6	477	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@@]([C@@]([H])([C@]([H])(C([H])([H])[H])[C@]([H])([C@@]([H])(O[H])[C@@]([H])(C([H])([H])[H])C(O[H])(C([H])([H])[H])C([H]) ([H])[H])O2)[C@]2([H])C3([H])[H])(C([H])([H])[H])[C@@]34O[H])C4=C([H])C5=O)[C@@]5([H])C([H])([H])[C@@]1([H])O[H]
TCMBANKIN039284	Polyporusterone E	polyporusterone e		460.65
TCMBANKIN039516	(22E,24R)-ergosta-7,22-dien-3-one		C28H44O	397	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])\C([H])=C([H])\[C@]([H])(C([H])([H])[H])C([H])(C([H])([H])[H])C([H ])([H])[H])C([H])([H])C2([H])[H])[C@]23[H])C3=C([H])C4([H])[H])[C@@]4([H])C([H])([H])C1=O
TCMBANKIN039993	ergosta-4,6,8(14),22-tetraen-3-one		C28H40O	392.6 g/mol	CC(C)C(C)C=CC(C)C1CCC2=C3C=CC4=CC(=O)CCC4(C3CCC12C)C
TCMBANKIN040495	polyporusterone A	CHEMBL404770; Polyporusterone A	C28H46O6	479	[C@@]1([H])(O[H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@@]([C@@]([H])([C@@]([C@]([H])(O[H])C([H])([H])[C@@]([H])(C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H])(C([H] )([H])[H])O[H])C([H])([H])C2([H])[H])(C([H])([H])[H])[C@@]23O[H])C3=C([H])C4=O)[C@@]4([H])C([H])([H])[C@@]1([H])O[H]
TCMBANKIN041519	Polyporusterone D	polyporusterone d		460.65
TCMBANKIN042151	ergosterol peroxide	ergosterol peroxide; 2061-64-5; ergosterolperoxide; dimethyl-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl][?]ol; (3.beta.,5.alpha.,8.alpha.,22E)-5,8-Epidioxyergosta-6,22-dien-3-ol	C56H86O2	791	O([C@]1([H])C([H])([H])C([C@@](C([H])([H])[H])([C@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])\C([H])=C([H])\[C@@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C ([H])([H])[H])C([H])([H])C2([H])[H])[C@]23[H])C3=C4[H])C([H])([H])C1([H])[H])=C4[H])O[C@]5([H])C([H])([H])C([C@@](C([H])([H])[H])([C@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([ H])(C([H])([H])[H])\C([H])=C([H])\[C@@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C6([H])[H])[C@]67[H])C7=C8[H])C([H])([H])C5([H])[H])=C8[H]
TCMBANKIN042638	(23r,24r,25r)-23,26-epoxy-3beta,14alpha,21alpha,22alpha-tetrahydroxyergost-7-en-6-one			476.72
TCMBANKIN044369	(22e,24r)-ergosta-6-en-3beta,5alpha,6beta-triol			432.76
TCMBANKIN045705	polyporusterone G	polyporusterone g	C28H44O5	460.65	CC(C)C(=C)CC(C(C)C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O
TCMBANKIN045773	polyporusterone F	polyporusterone f	C28H46O5	462.66	CC(C)C(C)CC(C(C)C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O
TCMBANKIN059115	polyporusterone b	141360-89-6; Polyporusterone B; CHEMBL260669; polyporusterone,b	C28H44O6	476.6 g/mol	CC(C)C(=C)CC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O
TCMBANKIN059144	ergosta-4,6,8(14),22-tetraen-3-one	ergosta-4,6,8(14),22,tetraen-3-one; AJ-54768; (22E)-Ergosta-4,6,8(14),22-tetren-3-one; (22e,24r)-ergosta-4,6,8(14),22-tetraen-3-one; MolPort-023-298-990; Ergosta-4,6,8(14),22-tetraen-3-one, (22E)-; Ergosta-4,6,8(14),22-tetraen-3-one; (1R,9AR,9BR,11AR)-1-[(2R,3E,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,8H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-ONE; CHEBI:69431; BG01104490; 19254-69-4; CHEMBL3588948; UNII-RI51Y55U8P; Ergone; (22E)-Ergosta-4,6,8(14),22-tetraen-3-one; AKOS022184779; SCHEMBL6365010; (9R,10R,13R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one; AK104269; AC1O5V9Q; 24-methylcholesta-4,6,8(14),22-tetraen-3-one; ZINC5761087; W2324; RI51Y55U8P; 27625-48-5; ergone; (9R,10R,13R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one; (9R,10R,13R,17R)-10,13-dimethyl-17-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one; 19254-69-4; Ergosta-4,6,8(14),22-tetraen-3-one, (22E)-	C28H40O	392.6 g/mol	CC(C)C(C)C=CC(C)C1CCC2=C3C=CC4=CC(=O)CCC4(C3CCC12C)C
TCMBANKIN059147	ergosterin	ergosterol;24-Methylcholesta-5,7,22-trien-3beta-ol; 24alpha-Methyl-22E-dehydrocholestero; (3beta,22E)-Ergosta-5,7,22-trien-3-ol; (7S,9AR,11AR)-1-[(2R,3E,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,6H,7H,8H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; 45480_FLUKA; (24R)-Ergosta-5,7,22-trien-3b-ol; MEGxm0_000450; Ergosterin; 24R-Methylcholesta-5,7,22E-trien-3b-ol; 57-87-4; Ergosterol; ergosta-5,7,22E-trien-3beta-ol; (3beta)-Ergosta-5,7,22-trien-3-ol; C01694; 5,7,22-Ergostatrien-3beta-ol; AIDS064232; E6510_SIGMA; Provitamin D2; (22E)-Ergosta-5,7,22-trien-3.beta.-ol; A831651; ergosta-5,7,22-trienol; ergosta-5,7,22-trien-3 beta-ol; 24R-Methylcholesta-5,7,22E-trien-3beta-ol; ACon0_000429; ERG; ST073383; (3S,10R,13R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; 24-Methylcholesta-5,7,22-trien-3b-ol; ACon1_000637; (3beta,2E)-Ergosta-5,7,22-trien-3-ol; Provitamine D2; AIDS-064232; 24a-Methyl-22E-dehydrocholesterol; ergosta-5,7,22-trien-3-ol; 47130U_SUPELCO; LMST01030093; (22E)-ergosta-5,7,22-trien-3beta-ol; ZINC04084618; (3S,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; 3beta-Hydroxy-5,7,22-ergostatriene; CHEBI:16933; (3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (22E,24S)-24-methylcholesta-5,7,22-trien-3beta-ol	C28H44O	396.6 g/mol	CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CC=C4C3(CCC(C4)O)C)C
TCMBANKIN059149	Ergosterol peroxide	2061-64-5; NSC31324; Ergosterol peroxide; 5.alpha.,8.alpha.-Ergosta-6,22-dien-3.beta.-ol, 5,8-epidioxy-; ERGOSTEROL-5,8-PEROXIDE; Ergosterol 5.alpha.,8.alpha.-epidioxide; Ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3.beta.,5.alpha.,8.alpha.,22E)-; Ergosterol endoperoxide; (3β,5α,8α,22E,24R)-5,8-Epidioxyergosta-6,22-dien-3-ol; 5,8-epidioxyergosta-6,22-dien-3-ol; Peroxyergosterol; ergosterol peroxide; 2061-64-5; ergosterolperoxide; dimethyl-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl][?]ol; (3.beta.,5.alpha.,8.alpha.,22E)-5,8-Epidioxyergosta-6,22-dien-3-ol	C28H44O3	428.6 g/mol	CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C24C=CC5(C3(CCC(C5)O)C)OO4)C
TCMBANKIN059150	polyporusterone c	polyporusterone C	C28H44O6	476.6 g/mol	CC(C)C(C)C1C(O1)C(C)(C2CCC3(C2(CCC4C3=CC(=O)C5C4(CC(C(C5)O)O)C)C)O)O

植物对应的疾病

疾病ID	病名	疾病类型	MeSH	参考文献

植物对应的靶点

靶点ID	基因名	基因别名	描述	染色体位置	Map_Location	基因类型

TCMBank_ID:

TCMBANKHE005505

ID:

TCMBANKHE005505

植物拉丁名:

polyporus umbellatus

功能与主治:

To transform dampness and promote water metabolism/Inhibited urination, edema, ascites, carcinoma of lung, carcinoma of esophagus, diarrhea, strangury-turbidity, vaginal discharge.

药用植物名:

猪苓

药用部位:

sclerotium

药味:

Mild; Sweet; Neutral

经络:

Bladder; Kidney

治疗类型:

利水渗湿药

TCM_ID_id:

4883

SymMap_id:

488

TCMSP_id:

883